Have you seen the latest news and insights on Cystic Fibrosis News Today?

Cystic Fibrosis Weekly Update Contents: AzurRx Begins Phase 2b Trial Testing MS1819 for Pancreatic Insufficiency in CF Patients AzurRx Begins Phase 2b Trial Testing MS1819 for Pancreatic Insufficiency in CF Patients Jul 27, 2020 07:00 am | David Melamed, PhD AzurRx BioPharma has launched a Phase 2b clinical trial investigating its MS1819 as a potential treatment for exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF). The first patient has now been screened in the OPTION 2 trial (NCT04375878), which has opened at three clinical sites to start. Researchers intend to enroll a total […] The post AzurRx Begins Phase 2b Trial Testing MS1819 for Pancreatic Insufficiency in CF Patients appeared first on Cystic Fibrosis News Today. Read More Recent News Plan A Didn’t Work — Now What? CF Patients in Wales Will Have Access to Kaftrio Under New Deal ContraFect Given Up to $18.9M to Advance CF-370 for P. aeruginosa Infections Inflammatory Markers May Help Predict Exacerbations in Children with CF Why Am I So Ashamed of Chronic Pain?